A Pilot Study of Fear of Disease Consequences and Its Relationship with Quality of Life, Depression and Anxiety inPatients with Multiple Sclerosis

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 338

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IAHS-6-3_004

تاریخ نمایه سازی: 3 اسفند 1398

Abstract:

Aims: This study aims to determine the relationship between fear of disease consequences and its relationship with quality of life, symptoms ofdepression, and anxiety in patients with multiple sclerosis (MS). Materials and Methods: This cross‑sectional study was conducted at TabrizUniversity of Medical Sciences. Seventy patients suffering from MS were selected using the convinced sampling method. Data collectiontools were included: Fear of Progression Questionnaire‑Short Form, World Health Organizations Quality of Life‑Brief, Beck DepressionInventory, and Beck Anxiety Inventory. Descriptive statistical methods, independent sample t‑test, one‑way ANOVA, Spearman’s correlationcoefficient test, and linear regression model were used to analyze data by SPSS.22 software. Results: In this study, 38 (54.3%) of patientswere male. Mean score of fear of the disease, quality of life, depression, and anxiety was 28.68 ± 9.18, 86.47 ± 14.11, 15.22 ± 4.86, and15.85 ± 5.55, respectively. Results of Spearman’s test indicated a significant relationship between fear of disease consequences on the onehand and quality of life (rs = −0.53), symptoms of depression (rs = −0.52), and anxiety (rs = −0.48) on the other hand (P < 0.001). Results oflinear regression analysis demonstrated that there is a strength correlation between depression – as the predictive variable – and quality oflife (P = 0.018, standard error [SE] = 0.793, β = −0.283 R2 = 0.57), and anxiety – as the predictive variable – and quality of life (P = 0.005,SE = 0.681, β = 0.332 R2 = 0.64). Conclusion: Considering negative effects of fear of the disease consequences on quality of life, symptomsof depression and anxiety, the patients should be informed about their own conditions, and appropriate mental and health cares should beprovided, and effective interventions should be done to alleviate the fear of the patients.

Keywords:

Authors

Saber Azami-Aghdash

Tabriz Health Services Management Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences

Morteza Ghojazadeh

Research Center for Evidence‑Based Medicine, Tabriz University of Medical Sciences

Mohammad Naghavi-Behzad

Students’ Research Committee, Tabriz University of Medical Sciences

Naser Derakhshani

Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran

Vida Poudratchi Asl

Ardabil Azad University, Ardabil, Iran

Behrouz Samei

Department of Health Services Management, Iranian Center of Excellence in Health Management, Tabriz University of Medical Sciences, Tabriz